900 Blake Wilbur Drive - First Floor
Stanford, CA 94305
Stanford Gynecologic Oncology
The Stanford Gynecologic Oncology program offers expert treatment for patients with ovarian, cervical, uterine and other cancers of the reproductive system. Our physicians subspecialize in treating these types of cancers, and have extensive expertise managing all types of cases, including the most complicated.
Located in the new Stanford Women’s Cancer Center, a warm and welcoming facility, our program offers comprehensive treatment options and supportive services that honor your unique needs:
- Convenient, single location for most of your outpatient cancer care
- Advanced treatments, including minimally invasive surgery, state-of-the art radiotherapy and cutting-edge clinical trials
- Weekly tumor board meetings with cancer experts to review your case and discuss therapeutic options on site
- Guest service professionals to help you navigate and manage treatment, and a wide array of supportive services, including counseling for psychological issues, sexual side effects and changes in body image
- Collaborative research to improve cancer prevention, detection, treatment and patient outcomes
- Survivorship Clinic to focus on post-cancer wellness
Early Detection, Integrated Treatment Key to Outcomes
With ovarian cancer patient Lane Baker and her physician, Jonathan Berek, MD, MMS
Types Of Gynecologic Cancers
Our physicians provide care for women with all types of gynecologic cancers. Learn more about:
Meet Our Physicians
Treatment & Research
As a patient at Stanford’s Women’s Cancer Center, you’ll benefit from our integrated treatment programs. Read more »
Our gynecologic cancer patients benefit from world-class research, and access to experimental therapies and clinical trials at Stanford. Read more »
The BRCA Decision Tool guides the management of cancer risks for BRCA1 and BRCA2 mutation carriers, helping Melanie Lemons understand options and make critical decisions. Read more »
[ close x ]
Treatment options:
- State-of-the-art surgical techniques to address metastatic tumors
- Advanced minimally invasive surgery, including use of robotics to enhance complex procedures, minimize patient stays and speed recovery times
- Intra-operative radiation therapy (IORT), which delivers high-dose radiation directly to a patient�s tumor site during surgery
- New and investigational treatments, including PARP inhibitors, immunotherapies such as dendritic cell therapy, and ovarian cancer vaccines
- Fertility-conserving surgery and advanced assisted reproductive technology to help maximize your childbearing options
[ close x ]
Clinical research:
- Stem cell research that may influence new treatments
- Early detection of ovarian cancer using biomarkers and new methods of imaging
- Understanding drug resistance in certain ovarian cancers
- New ways of classifying ovarian cancer; development of vaccines to prevent relapse
- Use of novel chemotherapeutics in uterine tumors
- Mechanisms of HPV-induced malignancy, and new prevention and detection strategies for cervical cancer
- Clinical trials studying novel chemotherapeutic agents, prophylactic chemotherapy, biologic agents, angiogenesis inhibitors, vaccines and antibody therapies
See a complete list of clinical trials
Trial Administration